Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Pope urges news agencies to stand as bulwark against lies, manipulation and post-truths

Pope Leo XIV has encouraged international news agencies to stand firm as a bulwark against the “ancient art of lying” and manipulation.

A list of this year’s Nobel Prize winners

The award of the Nobel Peace Prize to Venezuelan opposition leader María Corina Machado has brought this week’s Nobel announcements to a conclusion.

Big Business This Week: Are Oracle’s profit margins getting squeezed?

When stocks in one sector suddenly start jumping, and investors and industry players are pouring in hundreds of billions, is there a bubble?

Shutdown in the Skies: How Air Traffic Control Is Feeling the Turbulence

Skift airline reporter Meghna Maharishi breaks down how the government shutdown is hitting air traffic control—and what it means for travelers and flight safety

Behind the Boom: Aya Kantorovich on Bitcoin Highs, ETFs, and Institutional Crypto

Aya Kantorovich, Co-CEO of August Digital, breaks down Bitcoin’s surge, crypto ETFs, institutional investment trends, and the future of safer crypto access.

Why AI “actress” Tilly Norwood is no threat to Hollywood

Tilly Norwood, the AI “actress” that has tinsel town talking, is nothing to fear.

Load More